Loading…

Midbrain Gene Screening Identifies a New Mesoaccumbal Glutamatergic Pathway and a Marker for Dopamine Cells Neuroprotected in Parkinson’s Disease

The ventral tegmental area (VTA) and substantia nigra pars compacta (SNc) of the midbrain are associated with Parkinson’s disease (PD), schizophrenia, mood disorders and addiction. Based on the recently unraveled heterogeneity within the VTA and SNc, where glutamate, GABA and co-releasing neurons ha...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2016-10, Vol.6 (1), p.35203-35203, Article 35203
Main Authors: Viereckel, Thomas, Dumas, Sylvie, Smith-Anttila, Casey J. A., Vlcek, Bianca, Bimpisidis, Zisis, Lagerström, Malin C., Konradsson-Geuken, Åsa, Wallén-Mackenzie, Åsa
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c475t-7d4e5cc96319b4b394bec2def407ce5f0c89248ff4b96ca435474a1ebd6a683e3
cites cdi_FETCH-LOGICAL-c475t-7d4e5cc96319b4b394bec2def407ce5f0c89248ff4b96ca435474a1ebd6a683e3
container_end_page 35203
container_issue 1
container_start_page 35203
container_title Scientific reports
container_volume 6
creator Viereckel, Thomas
Dumas, Sylvie
Smith-Anttila, Casey J. A.
Vlcek, Bianca
Bimpisidis, Zisis
Lagerström, Malin C.
Konradsson-Geuken, Åsa
Wallén-Mackenzie, Åsa
description The ventral tegmental area (VTA) and substantia nigra pars compacta (SNc) of the midbrain are associated with Parkinson’s disease (PD), schizophrenia, mood disorders and addiction. Based on the recently unraveled heterogeneity within the VTA and SNc, where glutamate, GABA and co-releasing neurons have been found to co-exist with the classical dopamine neurons, there is a compelling need for identification of gene expression patterns that represent this heterogeneity and that are of value for development of human therapies. Here, several unique gene expression patterns were identified in the mouse midbrain of which NeuroD6 and Grp were expressed within different dopaminergic subpopulations of the VTA, and TrpV1 within a small heterogeneous population. Optogenetics-coupled in vivo amperometry revealed a previously unknown glutamatergic mesoaccumbal pathway characterized by TrpV1-Cre -expression. Human GRP was strongly detected in non-melanized dopaminergic neurons within the SNc of both control and PD brains, suggesting GRP as a marker for neuroprotected neurons in PD. This study thus unravels markers for distinct subpopulations of neurons within the mouse and human midbrain, defines unique anatomical subregions within the VTA and exposes an entirely new glutamatergic pathway. Finally, both TRPV1 and GRP are implied in midbrain physiology of importance to neurological and neuropsychiatric disorders.
doi_str_mv 10.1038/srep35203
format article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_DiVA_org_uu_307529</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1835508737</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-7d4e5cc96319b4b394bec2def407ce5f0c89248ff4b96ca435474a1ebd6a683e3</originalsourceid><addsrcrecordid>eNplks9u1DAQxiMEolXpgRdAlrgAYsGO7Ti5IFW7sFTqQiX-XC3HmWxdEjvYCaveeAdOvB5PwqBdVlvwxZbm529mPn1Z9pDRF4zy8mWKMHCZU34nO86pkLOc5_ndg_dRdprSNcUj80qw6n52lCtV5JxVx9mPlWvqaJwnS_BAPtgI4J1fk_MG_OhaB4kY8g42ZAUpGGunvjYdWXbTaHozQlw7Sy7NeLUxN8T4BuGViV8gkjZEsgiD6R3qzqHrEspMMQwxjGBHaAg2vUTW-RT8r-8_E1m4BCbBg-xea7oEp7v7JPv05vXH-dvZxfvl-fzsYmaFkuNMNQKktVWBi9Si5pWoweYNtIIqC7KltqxyUbatqKvCGsGlUMIwqJvCFCUHfpI93-qmDQxTrYfoehNvdDBOL9znMx3iWk-T5lShc4i_2uLI9tBY9Cea7tav2xXvrvQ6fNOSKlaWBQo82QnE8HWCNOreJYvOGA9hSpqVXEpaKq4QffwPeh2m6NENpKqKMSpVidTTLWVjSJiDdj8Mo_pPOPQ-HMg-Opx-T_6NAgLPdm5gya8hHrT8T-0356LHRg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1899110578</pqid></control><display><type>article</type><title>Midbrain Gene Screening Identifies a New Mesoaccumbal Glutamatergic Pathway and a Marker for Dopamine Cells Neuroprotected in Parkinson’s Disease</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><source>Free Full-Text Journals in Chemistry</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Viereckel, Thomas ; Dumas, Sylvie ; Smith-Anttila, Casey J. A. ; Vlcek, Bianca ; Bimpisidis, Zisis ; Lagerström, Malin C. ; Konradsson-Geuken, Åsa ; Wallén-Mackenzie, Åsa</creator><creatorcontrib>Viereckel, Thomas ; Dumas, Sylvie ; Smith-Anttila, Casey J. A. ; Vlcek, Bianca ; Bimpisidis, Zisis ; Lagerström, Malin C. ; Konradsson-Geuken, Åsa ; Wallén-Mackenzie, Åsa</creatorcontrib><description>The ventral tegmental area (VTA) and substantia nigra pars compacta (SNc) of the midbrain are associated with Parkinson’s disease (PD), schizophrenia, mood disorders and addiction. Based on the recently unraveled heterogeneity within the VTA and SNc, where glutamate, GABA and co-releasing neurons have been found to co-exist with the classical dopamine neurons, there is a compelling need for identification of gene expression patterns that represent this heterogeneity and that are of value for development of human therapies. Here, several unique gene expression patterns were identified in the mouse midbrain of which NeuroD6 and Grp were expressed within different dopaminergic subpopulations of the VTA, and TrpV1 within a small heterogeneous population. Optogenetics-coupled in vivo amperometry revealed a previously unknown glutamatergic mesoaccumbal pathway characterized by TrpV1-Cre -expression. Human GRP was strongly detected in non-melanized dopaminergic neurons within the SNc of both control and PD brains, suggesting GRP as a marker for neuroprotected neurons in PD. This study thus unravels markers for distinct subpopulations of neurons within the mouse and human midbrain, defines unique anatomical subregions within the VTA and exposes an entirely new glutamatergic pathway. Finally, both TRPV1 and GRP are implied in midbrain physiology of importance to neurological and neuropsychiatric disorders.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/srep35203</identifier><identifier>PMID: 27762319</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>38/61 ; 45/77 ; 631/378/340 ; 631/378/3920 ; 64/110 ; 64/60 ; 9/10 ; 9/74 ; Addictions ; Amperometry ; Animals ; Basic Helix-Loop-Helix Transcription Factors - genetics ; Basic Helix-Loop-Helix Transcription Factors - metabolism ; Capsaicin receptors ; Dopamine ; Dopamine - metabolism ; Dopamine receptors ; Dopaminergic Neurons - metabolism ; Dopaminergic Neurons - pathology ; GABAergic Neurons - metabolism ; GABAergic Neurons - pathology ; gamma-Aminobutyric Acid - metabolism ; Gastrin-Releasing Peptide - genetics ; Gastrin-Releasing Peptide - metabolism ; Gene expression ; Gene Expression Regulation ; Genetics ; Glutamatergic transmission ; Glutamic Acid - metabolism ; Heterogeneity ; Humanities and Social Sciences ; Humans ; Information processing ; Mental disorders ; Mesencephalon ; Mice ; Mice, Transgenic ; Mood ; Movement disorders ; multidisciplinary ; Nerve Tissue Proteins - genetics ; Nerve Tissue Proteins - metabolism ; Neurodegenerative diseases ; Neurological diseases ; Neurons ; Optics ; Optogenetics ; Parkinson Disease - genetics ; Parkinson Disease - metabolism ; Parkinson Disease - pathology ; Parkinson's disease ; Pars Compacta - metabolism ; Pars Compacta - pathology ; Rodents ; Schizophrenia ; Science ; Subpopulations ; Substantia nigra ; Synaptic Transmission ; TRPV Cation Channels - genetics ; TRPV Cation Channels - metabolism ; Ventral Tegmental Area - metabolism ; Ventral Tegmental Area - pathology ; Ventral tegmentum ; γ-Aminobutyric acid</subject><ispartof>Scientific reports, 2016-10, Vol.6 (1), p.35203-35203, Article 35203</ispartof><rights>The Author(s) 2016</rights><rights>Copyright Nature Publishing Group Oct 2016</rights><rights>Copyright © 2016, The Author(s) 2016 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-7d4e5cc96319b4b394bec2def407ce5f0c89248ff4b96ca435474a1ebd6a683e3</citedby><cites>FETCH-LOGICAL-c475t-7d4e5cc96319b4b394bec2def407ce5f0c89248ff4b96ca435474a1ebd6a683e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1899110578/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1899110578?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,36992,44569,53769,53771,74872</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27762319$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-307529$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Viereckel, Thomas</creatorcontrib><creatorcontrib>Dumas, Sylvie</creatorcontrib><creatorcontrib>Smith-Anttila, Casey J. A.</creatorcontrib><creatorcontrib>Vlcek, Bianca</creatorcontrib><creatorcontrib>Bimpisidis, Zisis</creatorcontrib><creatorcontrib>Lagerström, Malin C.</creatorcontrib><creatorcontrib>Konradsson-Geuken, Åsa</creatorcontrib><creatorcontrib>Wallén-Mackenzie, Åsa</creatorcontrib><title>Midbrain Gene Screening Identifies a New Mesoaccumbal Glutamatergic Pathway and a Marker for Dopamine Cells Neuroprotected in Parkinson’s Disease</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>The ventral tegmental area (VTA) and substantia nigra pars compacta (SNc) of the midbrain are associated with Parkinson’s disease (PD), schizophrenia, mood disorders and addiction. Based on the recently unraveled heterogeneity within the VTA and SNc, where glutamate, GABA and co-releasing neurons have been found to co-exist with the classical dopamine neurons, there is a compelling need for identification of gene expression patterns that represent this heterogeneity and that are of value for development of human therapies. Here, several unique gene expression patterns were identified in the mouse midbrain of which NeuroD6 and Grp were expressed within different dopaminergic subpopulations of the VTA, and TrpV1 within a small heterogeneous population. Optogenetics-coupled in vivo amperometry revealed a previously unknown glutamatergic mesoaccumbal pathway characterized by TrpV1-Cre -expression. Human GRP was strongly detected in non-melanized dopaminergic neurons within the SNc of both control and PD brains, suggesting GRP as a marker for neuroprotected neurons in PD. This study thus unravels markers for distinct subpopulations of neurons within the mouse and human midbrain, defines unique anatomical subregions within the VTA and exposes an entirely new glutamatergic pathway. Finally, both TRPV1 and GRP are implied in midbrain physiology of importance to neurological and neuropsychiatric disorders.</description><subject>38/61</subject><subject>45/77</subject><subject>631/378/340</subject><subject>631/378/3920</subject><subject>64/110</subject><subject>64/60</subject><subject>9/10</subject><subject>9/74</subject><subject>Addictions</subject><subject>Amperometry</subject><subject>Animals</subject><subject>Basic Helix-Loop-Helix Transcription Factors - genetics</subject><subject>Basic Helix-Loop-Helix Transcription Factors - metabolism</subject><subject>Capsaicin receptors</subject><subject>Dopamine</subject><subject>Dopamine - metabolism</subject><subject>Dopamine receptors</subject><subject>Dopaminergic Neurons - metabolism</subject><subject>Dopaminergic Neurons - pathology</subject><subject>GABAergic Neurons - metabolism</subject><subject>GABAergic Neurons - pathology</subject><subject>gamma-Aminobutyric Acid - metabolism</subject><subject>Gastrin-Releasing Peptide - genetics</subject><subject>Gastrin-Releasing Peptide - metabolism</subject><subject>Gene expression</subject><subject>Gene Expression Regulation</subject><subject>Genetics</subject><subject>Glutamatergic transmission</subject><subject>Glutamic Acid - metabolism</subject><subject>Heterogeneity</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Information processing</subject><subject>Mental disorders</subject><subject>Mesencephalon</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Mood</subject><subject>Movement disorders</subject><subject>multidisciplinary</subject><subject>Nerve Tissue Proteins - genetics</subject><subject>Nerve Tissue Proteins - metabolism</subject><subject>Neurodegenerative diseases</subject><subject>Neurological diseases</subject><subject>Neurons</subject><subject>Optics</subject><subject>Optogenetics</subject><subject>Parkinson Disease - genetics</subject><subject>Parkinson Disease - metabolism</subject><subject>Parkinson Disease - pathology</subject><subject>Parkinson's disease</subject><subject>Pars Compacta - metabolism</subject><subject>Pars Compacta - pathology</subject><subject>Rodents</subject><subject>Schizophrenia</subject><subject>Science</subject><subject>Subpopulations</subject><subject>Substantia nigra</subject><subject>Synaptic Transmission</subject><subject>TRPV Cation Channels - genetics</subject><subject>TRPV Cation Channels - metabolism</subject><subject>Ventral Tegmental Area - metabolism</subject><subject>Ventral Tegmental Area - pathology</subject><subject>Ventral tegmentum</subject><subject>γ-Aminobutyric acid</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNplks9u1DAQxiMEolXpgRdAlrgAYsGO7Ti5IFW7sFTqQiX-XC3HmWxdEjvYCaveeAdOvB5PwqBdVlvwxZbm529mPn1Z9pDRF4zy8mWKMHCZU34nO86pkLOc5_ndg_dRdprSNcUj80qw6n52lCtV5JxVx9mPlWvqaJwnS_BAPtgI4J1fk_MG_OhaB4kY8g42ZAUpGGunvjYdWXbTaHozQlw7Sy7NeLUxN8T4BuGViV8gkjZEsgiD6R3qzqHrEspMMQwxjGBHaAg2vUTW-RT8r-8_E1m4BCbBg-xea7oEp7v7JPv05vXH-dvZxfvl-fzsYmaFkuNMNQKktVWBi9Si5pWoweYNtIIqC7KltqxyUbatqKvCGsGlUMIwqJvCFCUHfpI93-qmDQxTrYfoehNvdDBOL9znMx3iWk-T5lShc4i_2uLI9tBY9Cea7tav2xXvrvQ6fNOSKlaWBQo82QnE8HWCNOreJYvOGA9hSpqVXEpaKq4QffwPeh2m6NENpKqKMSpVidTTLWVjSJiDdj8Mo_pPOPQ-HMg-Opx-T_6NAgLPdm5gya8hHrT8T-0356LHRg</recordid><startdate>20161020</startdate><enddate>20161020</enddate><creator>Viereckel, Thomas</creator><creator>Dumas, Sylvie</creator><creator>Smith-Anttila, Casey J. A.</creator><creator>Vlcek, Bianca</creator><creator>Bimpisidis, Zisis</creator><creator>Lagerström, Malin C.</creator><creator>Konradsson-Geuken, Åsa</creator><creator>Wallén-Mackenzie, Åsa</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>ACNBI</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>DF2</scope><scope>ZZAVC</scope></search><sort><creationdate>20161020</creationdate><title>Midbrain Gene Screening Identifies a New Mesoaccumbal Glutamatergic Pathway and a Marker for Dopamine Cells Neuroprotected in Parkinson’s Disease</title><author>Viereckel, Thomas ; Dumas, Sylvie ; Smith-Anttila, Casey J. A. ; Vlcek, Bianca ; Bimpisidis, Zisis ; Lagerström, Malin C. ; Konradsson-Geuken, Åsa ; Wallén-Mackenzie, Åsa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-7d4e5cc96319b4b394bec2def407ce5f0c89248ff4b96ca435474a1ebd6a683e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>38/61</topic><topic>45/77</topic><topic>631/378/340</topic><topic>631/378/3920</topic><topic>64/110</topic><topic>64/60</topic><topic>9/10</topic><topic>9/74</topic><topic>Addictions</topic><topic>Amperometry</topic><topic>Animals</topic><topic>Basic Helix-Loop-Helix Transcription Factors - genetics</topic><topic>Basic Helix-Loop-Helix Transcription Factors - metabolism</topic><topic>Capsaicin receptors</topic><topic>Dopamine</topic><topic>Dopamine - metabolism</topic><topic>Dopamine receptors</topic><topic>Dopaminergic Neurons - metabolism</topic><topic>Dopaminergic Neurons - pathology</topic><topic>GABAergic Neurons - metabolism</topic><topic>GABAergic Neurons - pathology</topic><topic>gamma-Aminobutyric Acid - metabolism</topic><topic>Gastrin-Releasing Peptide - genetics</topic><topic>Gastrin-Releasing Peptide - metabolism</topic><topic>Gene expression</topic><topic>Gene Expression Regulation</topic><topic>Genetics</topic><topic>Glutamatergic transmission</topic><topic>Glutamic Acid - metabolism</topic><topic>Heterogeneity</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Information processing</topic><topic>Mental disorders</topic><topic>Mesencephalon</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Mood</topic><topic>Movement disorders</topic><topic>multidisciplinary</topic><topic>Nerve Tissue Proteins - genetics</topic><topic>Nerve Tissue Proteins - metabolism</topic><topic>Neurodegenerative diseases</topic><topic>Neurological diseases</topic><topic>Neurons</topic><topic>Optics</topic><topic>Optogenetics</topic><topic>Parkinson Disease - genetics</topic><topic>Parkinson Disease - metabolism</topic><topic>Parkinson Disease - pathology</topic><topic>Parkinson's disease</topic><topic>Pars Compacta - metabolism</topic><topic>Pars Compacta - pathology</topic><topic>Rodents</topic><topic>Schizophrenia</topic><topic>Science</topic><topic>Subpopulations</topic><topic>Substantia nigra</topic><topic>Synaptic Transmission</topic><topic>TRPV Cation Channels - genetics</topic><topic>TRPV Cation Channels - metabolism</topic><topic>Ventral Tegmental Area - metabolism</topic><topic>Ventral Tegmental Area - pathology</topic><topic>Ventral tegmentum</topic><topic>γ-Aminobutyric acid</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Viereckel, Thomas</creatorcontrib><creatorcontrib>Dumas, Sylvie</creatorcontrib><creatorcontrib>Smith-Anttila, Casey J. A.</creatorcontrib><creatorcontrib>Vlcek, Bianca</creatorcontrib><creatorcontrib>Bimpisidis, Zisis</creatorcontrib><creatorcontrib>Lagerström, Malin C.</creatorcontrib><creatorcontrib>Konradsson-Geuken, Åsa</creatorcontrib><creatorcontrib>Wallén-Mackenzie, Åsa</creatorcontrib><collection>SpringerOpen</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SWEPUB Uppsala universitet full text</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SWEPUB Uppsala universitet</collection><collection>SwePub Articles full text</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Viereckel, Thomas</au><au>Dumas, Sylvie</au><au>Smith-Anttila, Casey J. A.</au><au>Vlcek, Bianca</au><au>Bimpisidis, Zisis</au><au>Lagerström, Malin C.</au><au>Konradsson-Geuken, Åsa</au><au>Wallén-Mackenzie, Åsa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Midbrain Gene Screening Identifies a New Mesoaccumbal Glutamatergic Pathway and a Marker for Dopamine Cells Neuroprotected in Parkinson’s Disease</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2016-10-20</date><risdate>2016</risdate><volume>6</volume><issue>1</issue><spage>35203</spage><epage>35203</epage><pages>35203-35203</pages><artnum>35203</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>The ventral tegmental area (VTA) and substantia nigra pars compacta (SNc) of the midbrain are associated with Parkinson’s disease (PD), schizophrenia, mood disorders and addiction. Based on the recently unraveled heterogeneity within the VTA and SNc, where glutamate, GABA and co-releasing neurons have been found to co-exist with the classical dopamine neurons, there is a compelling need for identification of gene expression patterns that represent this heterogeneity and that are of value for development of human therapies. Here, several unique gene expression patterns were identified in the mouse midbrain of which NeuroD6 and Grp were expressed within different dopaminergic subpopulations of the VTA, and TrpV1 within a small heterogeneous population. Optogenetics-coupled in vivo amperometry revealed a previously unknown glutamatergic mesoaccumbal pathway characterized by TrpV1-Cre -expression. Human GRP was strongly detected in non-melanized dopaminergic neurons within the SNc of both control and PD brains, suggesting GRP as a marker for neuroprotected neurons in PD. This study thus unravels markers for distinct subpopulations of neurons within the mouse and human midbrain, defines unique anatomical subregions within the VTA and exposes an entirely new glutamatergic pathway. Finally, both TRPV1 and GRP are implied in midbrain physiology of importance to neurological and neuropsychiatric disorders.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>27762319</pmid><doi>10.1038/srep35203</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2045-2322
ispartof Scientific reports, 2016-10, Vol.6 (1), p.35203-35203, Article 35203
issn 2045-2322
2045-2322
language eng
recordid cdi_swepub_primary_oai_DiVA_org_uu_307529
source Open Access: PubMed Central; Publicly Available Content Database; Free Full-Text Journals in Chemistry; Springer Nature - nature.com Journals - Fully Open Access
subjects 38/61
45/77
631/378/340
631/378/3920
64/110
64/60
9/10
9/74
Addictions
Amperometry
Animals
Basic Helix-Loop-Helix Transcription Factors - genetics
Basic Helix-Loop-Helix Transcription Factors - metabolism
Capsaicin receptors
Dopamine
Dopamine - metabolism
Dopamine receptors
Dopaminergic Neurons - metabolism
Dopaminergic Neurons - pathology
GABAergic Neurons - metabolism
GABAergic Neurons - pathology
gamma-Aminobutyric Acid - metabolism
Gastrin-Releasing Peptide - genetics
Gastrin-Releasing Peptide - metabolism
Gene expression
Gene Expression Regulation
Genetics
Glutamatergic transmission
Glutamic Acid - metabolism
Heterogeneity
Humanities and Social Sciences
Humans
Information processing
Mental disorders
Mesencephalon
Mice
Mice, Transgenic
Mood
Movement disorders
multidisciplinary
Nerve Tissue Proteins - genetics
Nerve Tissue Proteins - metabolism
Neurodegenerative diseases
Neurological diseases
Neurons
Optics
Optogenetics
Parkinson Disease - genetics
Parkinson Disease - metabolism
Parkinson Disease - pathology
Parkinson's disease
Pars Compacta - metabolism
Pars Compacta - pathology
Rodents
Schizophrenia
Science
Subpopulations
Substantia nigra
Synaptic Transmission
TRPV Cation Channels - genetics
TRPV Cation Channels - metabolism
Ventral Tegmental Area - metabolism
Ventral Tegmental Area - pathology
Ventral tegmentum
γ-Aminobutyric acid
title Midbrain Gene Screening Identifies a New Mesoaccumbal Glutamatergic Pathway and a Marker for Dopamine Cells Neuroprotected in Parkinson’s Disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T00%3A29%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Midbrain%20Gene%20Screening%20Identifies%20a%20New%20Mesoaccumbal%20Glutamatergic%20Pathway%20and%20a%20Marker%20for%20Dopamine%20Cells%20Neuroprotected%20in%20Parkinson%E2%80%99s%20Disease&rft.jtitle=Scientific%20reports&rft.au=Viereckel,%20Thomas&rft.date=2016-10-20&rft.volume=6&rft.issue=1&rft.spage=35203&rft.epage=35203&rft.pages=35203-35203&rft.artnum=35203&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/srep35203&rft_dat=%3Cproquest_swepu%3E1835508737%3C/proquest_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c475t-7d4e5cc96319b4b394bec2def407ce5f0c89248ff4b96ca435474a1ebd6a683e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1899110578&rft_id=info:pmid/27762319&rfr_iscdi=true